Patents by Inventor Jarrod Mousa

Jarrod Mousa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN MONOCLONAL ANTIBODIES AGAINST PNEUMOCOCCAL ANTIGENS
    Publication number: 20240117019
    Abstract: Monoclonal antibodies and antigen binding fragments that specifically bind pneumococcal proteins, specifically pneumococcal histidine triad protein (PhtD) and pneumococcal surface protein A (PspA), are provided. Also disclosed are nucleic acid molecules encoding the antibody, antigen binding fragment, a VH or VL of the antibody, or a multipiece antibody including the VH and/or VL, vectors including these nucleic acid molecules, and host cells transfected with these vectors. Methods of inhibiting, treating, and detecting a Streptococcus pneumoniae infection are also provided.
    Type: Application
    Filed: February 7, 2022
    Publication date: April 11, 2024
    Applicant: University of Georgia Research Foundation, Inc.
    Inventors: Jarrod Mousa, Aaron Gingerich, Jiachen Huang, Fredejah Royer, Fikri Y. Avci
  • ANTIBODIES THAT BIND HUMAN METAPNEUMOVIRUS FUSION PROTEIN AND THEIR USE
    Publication number: 20230085439
    Abstract: Antibodies and antigen binding fragments that specifically bind to human metapneumovirus (hMPV) F protein and neutralize hMPV are disclosed. Nucleic acids encoding these antibodies, vectors and host cells are also provided. The disclosed antibodies, antigen binding fragments, nucleic acids and vectors can be used, for example, to inhibit an hMPV infection or detect a hMPV infection.
    Type: Application
    Filed: May 21, 2019
    Publication date: March 16, 2023
    Applicant: University of Georgia Research Foundation, Inc.
    Inventors: Jarrod Mousa, Ralph A. Tripp, Jiachen Huang
  • Antibodies to human respiratory syncytial virus protein F pre-fusion conformation and methods of use therefor
    Patent number: 11524994
    Abstract: The present disclosure is directed to antibodies binding to human respiratory syncytial virus F protein, including both neutralizing and non-neutralizing antibodies, and methods for use thereof.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: December 13, 2022
    Assignee: VANDERBILT UNIVERSITY
    Inventors: James E. Crowe, Jr., Jarrod Mousa
  • ANTIBODIES TO HUMAN RESPIRATORY SYNCYTIAL VIRUS PROTEIN F PRE-FUSION CONFORMATION AND METHODS OF USE THEREFOR
    Publication number: 20190367586
    Abstract: The present disclosure is directed to antibodies binding to human respiratory syncytial virus F protein, including both neutralizing and non-neutralizing antibodies, and methods for use thereof.
    Type: Application
    Filed: December 18, 2017
    Publication date: December 5, 2019
    Applicant: Vanderbilt University
    Inventors: James E. Crowe, JR., Jarrod Mousa
  • HUMAN RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES AND METHODS OF USE THEREFOR
    Publication number: 20190240316
    Abstract: The present disclosure is directed to antibodies binding to human respiratory syncytial virus F protein, including both neutralizing and non-neutralizing antibodies, and methods for use thereof.
    Type: Application
    Filed: October 16, 2017
    Publication date: August 8, 2019
    Applicant: Vanderbilt University
    Inventors: James E. Crowe, Jr., Jarrod Mousa